Related Content
Innovation
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
PR-M06-18-NI-030
Innovation
Partnerships Between Bayer and DoE Formed to Produce Radioactive Pharma Intermediate
PAO-M06-18-NI-003
Contributing Authors
Don has 12 years of experience in the pharma and medical device industry, working both in large firms as well as starting up a novel materials and actives company. Before joining Celanese in October 2013, Don led business development for the healthcare and life sciences division of CSIRO, one of the largest industrial product development firms in the world. Prior to CSIRO, he led a corporate development team at DuPont, and began his career in the catalysts and polyolefins businesses of ExxonMobil Chemical.
